Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Peter R Rhode
The IL-15 Superagonist ALT-803 Enhances Anti-Cd20 Antibody-Directed NK Cell ADCC and in Vivo Clearance of B Cell Lymphomas
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Related publications
Combining ROR1- Specific Chimeric Antigen Receptor (CAR) NK Cells With IL-15 Superagonist (N-803/Alt-803) to Target Chemotherapy Resistant Neuroblastoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Combining Dinutuximab With ALT-803 (IL-15 Superagonist) Significantly Improves the Activity of Ex Vivo Expanded Natural Killer Cells Against GD2 + Pediatric Solid Tumors (ST)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Elotuzumab Directly Enhances NK Cell Cytotoxicity Against Myeloma via CS1 Ligation: Evidence for Augmented NK Cell Function Complementing ADCC
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models
Cancer immunology research
Cancer Research
Immunology
Adipocyte IL-15 Regulates Local and Systemic NK Cell Development
Journal of Immunology
Allergy
Immunology
ADCC-Mediated CD56dim NK Cell Responses Are Associated With Early HBsAg Clearance in Acute HBV Infection
Pathogens and Immunity
The Diagnosis and Management of NK/T-cell Lymphomas
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
B Cell Therapy for Rheumatoid Arthritis: The Rituximab (Anti-Cd20) Experience
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Antibody-Targeted Paclitaxel Loaded Nanoparticles for the Treatment of CD20+ B-Cell Lymphoma
Scientific Reports
Multidisciplinary
